Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Eu-approved roactemra	-	-	-	-	[1] 46 💬
2	Roactemra	-	-	-	-	[9] 40, 41, 46, 51, 86, 107, 266, 271, 331 💬
3	Roactemra (r)	-	-	-	-	[1] 46 💬
4	Roactemra 162 mg	-	-	-	-	[2] 46, 51 💬
5	Roactemra 162 mg solution for injection in pre-filled syringe	-	-	-	-	[1] 41 💬
6	Roactemra 162 mg solution injectable en seringue préremplie	-	-	-	-	[1] 46 💬
7	Roactemra 20 mg/ml concentrado para solución para perfusión	-	-	-	-	[1] 46 💬
8	Roactemra 20 mg/ml concentrate for solution for infusion	-	-	-	-	[1] 46 💬
9	Roactemra 20 mg/ml concentrate for solution for infusion.	-	-	-	-	[1] 46 💬
10	Roactemra 20 mg/ml, concentrado para solución para perfusión	-	-	-	-	[2] 46, 271 💬
11	Roactemra 20mg/ml	-	-	-	-	[1] 40 💬
12	Roactemra(r)	-	-	-	-	[1] 46 💬
13	Roactemra®	-	-	-	-	[2] 46, 271 💬
14	Roactemra® 20mg/ml konzentrat	-	-	-	-	[1] 266 💬
15	Roactemra®ev product code: prd82321	-	-	-	-	[1] 46 💬
16	Tocilizumab (actemra or roactemra)	Tocilizumab	[1] D02596 💬	[1] IL6R 💬	[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	[1] 46 💬
17	Tocilizumab [roactemra/actemra]	Tocilizumab	[1] D02596 💬	[1] IL6R 💬	[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	[4] 46, 51, 107, 331 💬
18	Tocilizumab [roactemra]	Tocilizumab	[1] D02596 💬	[1] IL6R 💬	[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	[1] 46 💬